Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter Shortages Remove Shortages filter Summaries of opinion (7) Apply Summaries of opinion filter Withdrawn applications (11) Apply Withdrawn applications filter Paediatric investigation plans (163) Apply Paediatric investigation plans filter Orphan designations (93) Apply Orphan designations filter Direct healthcare professional communication (4) Apply Direct healthcare professional communication filter

Product number

Patient safety

Yes (7) Apply Yes filter

Authorisation status

Authorised (317) Apply Authorised filter Withdrawn (28) Apply Withdrawn filter

ATC code

Marketing authorisation date

From:

To:

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

From:

To:

Referral name

Referral status

European Commission final decision (17) Apply European Commission final decision filter

Referral safety status

Yes (6) Apply Yes filter

Referral type

Article 20 procedures (12) Apply Article 20 procedures filter Article 31 referrals (5) Apply Article 31 referrals filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (15) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (4) Apply Centrally and nationally authorised products (mixed) filter Centrally authorised product(s) (12) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (12) Apply Risk minimisation measures filter Suspension (2) Apply Suspension filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Decision date

From:

To:

Medicine type

Additional monitoring Remove Additional monitoring filter Accelerated assessment (42) Apply Accelerated assessment filter Biosimilar (68) Apply Biosimilar filter Conditional approval (31) Apply Conditional approval filter Exceptional circumstances (35) Apply Exceptional circumstances filter Generic (247) Apply Generic filter Orphan medicine (122) Apply Orphan medicine filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

362 results

Remove all filtersRemove all filters

Medicine Shortages Remove Shortages filter European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter

Categories Human Remove Human filter

Medicine type Additional monitoring Remove Additional monitoring filter

Sort by

List item

Human medicine European public assessment report (EPAR): Tecentriq (updated)

atezolizumab, Carcinoma, Transitional Cell, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 20/09/2017, , Revision: 9, Authorised, Last updated: 13/07/2020
List item

Human medicine European public assessment report (EPAR): Mektovi (updated)

binimetinib, Melanoma
Date of authorisation: 20/09/2018, , Revision: 3, Authorised, Last updated: 13/07/2020
List item

Human medicine European public assessment report (EPAR): Glivec (updated)

imatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Gastrointestinal Stromal Tumors, Dermatofibrosarcoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hypereosinophilic Syndrome
Date of authorisation: 07/11/2001, , Revision: 38, Authorised, Last updated: 13/07/2020
List item

Human medicine European public assessment report (EPAR): Juluca (updated)

dolutegravir sodium, rilpivirine hydrochloride, HIV Infections
Date of authorisation: 16/05/2018, , Revision: 3, Authorised, Last updated: 10/07/2020
List item

Human medicine European public assessment report (EPAR): Darzalex (updated)

Daratumumab, Multiple Myeloma
Date of authorisation: 20/05/2016, , , , Revision: 12, Authorised, Last updated: 10/07/2020
List item

Human medicine European public assessment report (EPAR): Trazimera (updated)

trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 26/07/2018, , , Revision: 6, Authorised, Last updated: 09/07/2020
List item

Human medicine European public assessment report (EPAR): Benlysta (updated)

belimumab, Lupus Erythematosus, Systemic
Date of authorisation: 13/07/2011, , Revision: 21, Authorised, Last updated: 09/07/2020
List item

Human medicine European public assessment report (EPAR): Trogarzo (updated)

Ibalizumab, HIV Infections
Date of authorisation: 26/09/2019, , Revision: 2, Authorised, Last updated: 09/07/2020
List item

Human medicine European public assessment report (EPAR): Elocta (updated)

efmoroctocog alfa, Hemophilia A
Date of authorisation: 18/11/2015, , Revision: 9, Authorised, Last updated: 08/07/2020
List item

Human medicine European public assessment report (EPAR): Picato (updated)

Ingenol mebutate, Keratosis, Actinic
Date of authorisation: 15/11/2012, , , Revision: 9, Withdrawn, Last updated: 08/07/2020
List item

Human medicine European public assessment report (EPAR): Cotellic (updated)

cobimetinib hemifumarate, Melanoma
Date of authorisation: 20/11/2015, , Revision: 8, Authorised, Last updated: 07/07/2020
List item

Human medicine European public assessment report (EPAR): Ondexxya (updated)

andexanet alfa, Drug-Related Side Effects and Adverse Reactions
Date of authorisation: 26/04/2019, , , Revision: 4, Authorised, Last updated: 07/07/2020
List item

Human medicine European public assessment report (EPAR): Taltz (updated)

ixekizumab, Psoriasis
Date of authorisation: 25/04/2016, , Revision: 10, Authorised, Last updated: 07/07/2020
List item

Human medicine European public assessment report (EPAR): Tavlesse (updated)

Fostamatinib disodium, Thrombocytopenia
Date of authorisation: 09/01/2020, , Revision: 2, Authorised, Last updated: 06/07/2020
List item

Human medicine European public assessment report (EPAR): Intuniv (updated)

guanfacine hydrochloride, Attention Deficit Disorder with Hyperactivity
Date of authorisation: 17/09/2015, , Revision: 7, Authorised, Last updated: 06/07/2020
List item

Human medicine European public assessment report (EPAR): Biktarvy (updated)

bictegravir, emtricitabine, tenofovir alafenamide, fumarate, HIV Infections
Date of authorisation: 21/06/2018, , Revision: 6, Authorised, Last updated: 03/07/2020
List item

Human medicine European public assessment report (EPAR): Synjardy (updated)

empagliflozin, metformin, Diabetes Mellitus, Type 2
Date of authorisation: 27/05/2015, , Revision: 16, Authorised, Last updated: 03/07/2020
List item

Human medicine European public assessment report (EPAR): Zoely (updated)

Nomegestrol acetate, estradiol, Contraception
Date of authorisation: 26/07/2011, , Revision: 19, Authorised, Last updated: 03/07/2020
List item

Human medicine European public assessment report (EPAR): Flixabi (updated)

infliximab, Spondylitis, Ankylosing, Arthritis, Rheumatoid, Crohn Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Psoriasis
Date of authorisation: 26/05/2016, , , Revision: 14, Authorised, Last updated: 03/07/2020
List item

Human medicine European public assessment report (EPAR): Dupixent (updated)

dupilumab, Dermatitis, Atopic
Date of authorisation: 27/09/2017, , Revision: 8, Authorised, Last updated: 02/07/2020
List item

Human medicine European public assessment report (EPAR): Vemlidy (updated)

tenofovir alafenamide fumarate, Hepatitis B
Date of authorisation: 09/01/2017, , Revision: 7, Authorised, Last updated: 02/07/2020
List item

Human medicine European public assessment report (EPAR): Kymriah (updated)

tisagenlecleucel, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Large B-Cell, Diffuse
Date of authorisation: 22/08/2018, , , Revision: 2, Authorised, Last updated: 29/06/2020
List item

Human medicine European public assessment report (EPAR): Spherox (updated)

spheroids of human autologous matrix-associated chondrocytes, Cartilage Diseases
Date of authorisation: 10/07/2017, , Revision: 4, Authorised, Last updated: 29/06/2020
List item

Human medicine European public assessment report (EPAR): Idelvion (updated)

albutrepenonacog alfa, Hemophilia B
Date of authorisation: 11/05/2016, , , Revision: 7, Authorised, Last updated: 29/06/2020
List item

Human medicine European public assessment report (EPAR): Symkevi (updated)

tezacaftor, ivacaftor, Cystic Fibrosis
Date of authorisation: 31/10/2018, , , Revision: 6, Authorised, Last updated: 26/06/2020